Teva Pharmaceutical Industries Limited provided earnings guidance for the year 2022. The company expects revenue to be in range of $15.6 billion to $16.2 billion, operating income to be in the range of $4.2 billion to $4.5 billion and EPS to be in the range of $2.40 to $2.60.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.6 USD | -0.92% | -1.75% | +58.86% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.86% | 18.98B | |
+39.05% | 727B | |
+30.57% | 592B | |
-7.77% | 347B | |
+15.56% | 319B | |
-0.57% | 274B | |
+12.55% | 238B | |
+6.65% | 204B | |
-6.09% | 203B | |
-3.13% | 160B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Limited Provides Earnings Guidance for the Year 2022